Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spartalizumab plus chemotherapy versus gemcitabine plus nab-paclitaxel in cancer (Japan)
jRCT2080225324Phase 2Terminated
- Start
- Aug 2020
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of spartalizumab in cancer (2 arms). Started Aug 2020; status: terminated.
02
Drugs
spartalizumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080225324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225324.